SynthesisActa neurochirurgica2026
Impact of perioperative glucocorticoids on postoperative recurrence and complications in chronic subdural hematoma: a systematic review and meta-analysis.
Synthesis in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic subdural hematoma (CSDH) is a common neurosurgical condition in older adults and is characterized by a high postoperative recurrence rate. The impact of systemic glucocorticoids administered perioperatively as an adjunct to surgical evacuation for CSDH remains uncertain.
methodsWe systematically searched PubMed, Embase, and the Cochrane Central Register of Controlled Trials from inception to 30 September 2025 for randomized controlled trials comparing glucocorticoids with placebo as we included randomized controlled trials comparing perioperative systemic glucocorticoids versus placebo as an adjunct to surgery for CSDH. Eligible studies enrolled adult patients (≥ 18 years) with radiologically confirmed CSDH. Relative risks (RRs) were calculated to assess clinical outcomes.
resultsSix randomized controlled trials involving a total of 1,374 patients were included. Compared with placebo, adjuvant perioperative glucocorticoid therapy significantly reduced the risk of postoperative recurrence of CSDH (RR = 0.39; 95% CI: 0.24-0.63; I
conclusionsPerioperative glucocorticoid therapy appears to reduce postoperative recurrence of chronic subdural hematoma. No clear increase in infection was observed, while the evidence for mortality remains imprecise and cannot exclude potential harm. However, glucocorticoids were associated with a higher risk of psychiatric symptoms compared with placebo. Clinicians should balance the benefit of reduced recurrence against the increased likelihood of psychiatric adverse events when considering glucocorticoids as adjuvant therapy in patients with CSDH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.